NDC 50090-4813 – Promethazine Hydrochloride
Promethazine Hydrochloride 25 mg/1 · Tablet · Oral
Product NDC50090-4813
Product details
- Brand name
- Promethazine Hydrochloride
- Generic name
- Promethazine Hydrochloride
- Labeler
- A-S Medication Solutions
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA040596
- Marketed since
- December 14, 2005
- Listing expires
- December 31, 2026
- Pharmacologic class
- Phenothiazine
Active ingredients
- Promethazine Hydrochloride 25 mg/1
Uses, dosage, side effects and warnings for Promethazine Hydrochloride →
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 50090-4813-0 | 12 TABLET in 1 BOTTLE (50090-4813-0) | Dec 27, 2019 |
| 50090-4813-1 | 10 TABLET in 1 BOTTLE (50090-4813-1) | Dec 27, 2019 |
| 50090-4813-5 | 60 TABLET in 1 BOTTLE (50090-4813-5) | Dec 27, 2019 |
| 50090-4813-6 | 20 TABLET in 1 BOTTLE (50090-4813-6) | Dec 27, 2019 |
| 50090-4813-9 | 30 TABLET in 1 BOTTLE (50090-4813-9) | Dec 27, 2019 |
Other Promethazine Hydrochloride products
- 50090-4811 Promethazine Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-6216 Promethazine Hydrochloride 12.5 mg/1 · Tablet · A-S Medication Solutions
- 50090-4750 Promethazine Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-4453 Promethazine Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-4608 Promethazine Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-6431 Promethazine Hydrochloride 6.25 mg/5mL · Syrup · A-S Medication Solutions
- 50090-4875 Promethazine Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-0879 Promethazine Hydrochloride 50 mg/mL · Injection · A-S Medication Solutions
- 50090-4812 Promethazine Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-4452 Promethazine Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-2747 Promethazine Hydrochloride 25 mg/1 · Suppository · A-S Medication Solutions
- 0591-5319 Promethazine Hydrochloride 50 mg/1 · Tablet · Actavis Pharma, Inc.